Fresenius Medical Care AG (FMS) Cash from Financing Activities (2009 - 2025)

Fresenius Medical Care AG's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$242.6 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 76.48% year-over-year to -$242.6 million; the TTM figure through Dec 2025 stood at -$1.6 billion (up 41.33% YoY), while the FY2025 annual figure was -$1.6 billion, up 40.51% from the prior year.
• Cash from Financing Activities was -$242.6 million for Q4 2025 at Fresenius Medical Care AG, up from -$1.3 billion in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $89.7 million in Q2 2025 to a low of -$1.3 billion in Q3 2025.
• Historically, Cash from Financing Activities has averaged -$466.1 million across 5 years, with a median of -$410.7 million in 2021.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities plunged 14656.63% in 2024, then soared 109.94% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$409.0 million in 2021, then surged by 70.09% to -$122.3 million in 2022, then tumbled by 555.76% to -$802.3 million in 2023, then decreased by 28.56% to -$1.0 billion in 2024, then soared by 76.48% to -$242.6 million in 2025.
• The last three Cash from Financing Activities figures came in at -$242.6 million (Q4 2025), -$1.3 billion (Q3 2025), and $89.7 million (Q2 2025), per Business Quant data.